These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193 [TBL] [Abstract][Full Text] [Related]
37. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia. Kaufman DM J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637 [TBL] [Abstract][Full Text] [Related]
38. Anterocollis: clinical features and treatment options. Papapetropoulos S; Tuchman A; Sengun C; Russell A; Mitsi G; Singer C Med Sci Monit; 2008 Sep; 14(9):CR427-30. PubMed ID: 18758411 [TBL] [Abstract][Full Text] [Related]
39. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin. Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419 [TBL] [Abstract][Full Text] [Related]
40. Cervical radiculopathy following botulinum toxin therapy for cervical dystonia. Defazio G; Lepore V; Melpignano C; Lamberti P; Livrea P; Ferrari E Funct Neurol; 1993; 8(3):193-6. PubMed ID: 8406138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]